267 related articles for article (PubMed ID: 24833397)
1. Mechanism of activation of protein kinase JAK2 by the growth hormone receptor.
Brooks AJ; Dai W; O'Mara ML; Abankwa D; Chhabra Y; Pelekanos RA; Gardon O; Tunny KA; Blucher KM; Morton CJ; Parker MW; Sierecki E; Gambin Y; Gomez GA; Alexandrov K; Wilson IA; Doxastakis M; Mark AE; Waters MJ
Science; 2014 May; 344(6185):1249783. PubMed ID: 24833397
[TBL] [Abstract][Full Text] [Related]
2. JAK2 activation by growth hormone and other cytokines.
Waters MJ; Brooks AJ
Biochem J; 2015 Feb; 466(1):1-11. PubMed ID: 25656053
[TBL] [Abstract][Full Text] [Related]
3. Fos-Zippered GH Receptor Cytosolic Tails Act as Jak2 Substrates and Signal Transducers.
Nespital T; van der Velden LM; Mensinga A; van der Vaart ED; Strous GJ
Mol Endocrinol; 2016 Mar; 30(3):290-301. PubMed ID: 26859362
[TBL] [Abstract][Full Text] [Related]
4. Regulation of JAK2 activation by Janus homology 2: evidence from molecular dynamics simulations.
Wan S; Coveney PV
J Chem Inf Model; 2012 Nov; 52(11):2992-3000. PubMed ID: 23033920
[TBL] [Abstract][Full Text] [Related]
5. The growth hormone receptor.
Waters MJ
Growth Horm IGF Res; 2016 Jun; 28():6-10. PubMed ID: 26059750
[TBL] [Abstract][Full Text] [Related]
6. On the regulation and activation of JAK2: a novel hypothetical model.
Lee TS
Mol Cancer Res; 2013 Aug; 11(8):811-4. PubMed ID: 23615525
[TBL] [Abstract][Full Text] [Related]
7. ATP binding to the pseudokinase domain of JAK2 is critical for pathogenic activation.
Hammarén HM; Ungureanu D; Grisouard J; Skoda RC; Hubbard SR; Silvennoinen O
Proc Natl Acad Sci U S A; 2015 Apr; 112(15):4642-7. PubMed ID: 25825724
[TBL] [Abstract][Full Text] [Related]
8. Model for growth hormone receptor activation based on subunit rotation within a receptor dimer.
Brown RJ; Adams JJ; Pelekanos RA; Wan Y; McKinstry WJ; Palethorpe K; Seeber RM; Monks TA; Eidne KA; Parker MW; Waters MJ
Nat Struct Mol Biol; 2005 Sep; 12(9):814-21. PubMed ID: 16116438
[TBL] [Abstract][Full Text] [Related]
9. New insights into the structure and function of the pseudokinase domain in JAK2.
Silvennoinen O; Ungureanu D; Niranjan Y; Hammaren H; Bandaranayake R; Hubbard SR
Biochem Soc Trans; 2013 Aug; 41(4):1002-7. PubMed ID: 23863170
[TBL] [Abstract][Full Text] [Related]
10. A JAK2 interdomain linker relays Epo receptor engagement signals to kinase activation.
Zhao L; Dong H; Zhang CC; Kinch L; Osawa M; Iacovino M; Grishin NV; Kyba M; Huang LJ
J Biol Chem; 2009 Sep; 284(39):26988-98. PubMed ID: 19638629
[TBL] [Abstract][Full Text] [Related]
11. The effects of R683S (G) genetic mutations on the JAK2 activity, structure and stability.
Li F; Guo HY; Wang M; Geng HL; Bian MR; Cao J; Chen C; Zeng LY; Wang XY; Wu QY
Int J Biol Macromol; 2013 Sep; 60():186-95. PubMed ID: 23748007
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of homodimeric cytokine receptor activation and dysregulation by oncogenic mutations.
Wilmes S; Hafer M; Vuorio J; Tucker JA; Winkelmann H; Löchte S; Stanly TA; Pulgar Prieto KD; Poojari C; Sharma V; Richter CP; Kurre R; Hubbard SR; Garcia KC; Moraga I; Vattulainen I; Hitchcock IS; Piehler J
Science; 2020 Feb; 367(6478):643-652. PubMed ID: 32029621
[TBL] [Abstract][Full Text] [Related]
13. Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A; Arai K
Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
[TBL] [Abstract][Full Text] [Related]
14. Structural and Functional Characterization of the JH2 Pseudokinase Domain of JAK Family Tyrosine Kinase 2 (TYK2).
Min X; Ungureanu D; Maxwell S; Hammarén H; Thibault S; Hillert EK; Ayres M; Greenfield B; Eksterowicz J; Gabel C; Walker N; Silvennoinen O; Wang Z
J Biol Chem; 2015 Nov; 290(45):27261-27270. PubMed ID: 26359499
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of the growth hormone-induced Janus kinase 2/signal transducer and activator of transcription 5 signaling pathway requires an intact actin cytoskeleton.
Rico-Bautista E; Negrín-Martínez C; Novoa-Mogollón J; Fernández-Perez L; Flores-Morales A
Exp Cell Res; 2004 Mar; 294(1):269-80. PubMed ID: 14980520
[TBL] [Abstract][Full Text] [Related]
16. An agonist-induced conformational change in the growth hormone receptor determines the choice of signalling pathway.
Rowlinson SW; Yoshizato H; Barclay JL; Brooks AJ; Behncken SN; Kerr LM; Millard K; Palethorpe K; Nielsen K; Clyde-Smith J; Hancock JF; Waters MJ
Nat Cell Biol; 2008 Jun; 10(6):740-7. PubMed ID: 18488018
[TBL] [Abstract][Full Text] [Related]
17. An unusual insertion in Jak2 is crucial for kinase activity and differentially affects cytokine responses.
Haan C; Kroy DC; Wüller S; Sommer U; Nöcker T; Rolvering C; Behrmann I; Heinrich PC; Haan S
J Immunol; 2009 Mar; 182(5):2969-77. PubMed ID: 19234192
[TBL] [Abstract][Full Text] [Related]
18. Hwanggeumchal sorghum extract enhances BMP7 and GH signaling through the activation of Jak2/STAT5B in MC3T3‑E1 osteoblastic cells.
Joung YH; Lim EJ; Darvin P; Jang JW; Park KD; Lee HK; Kim HS; Cho BW; Park T; Chung S; Park JH; Yang YM
Mol Med Rep; 2013 Sep; 8(3):891-6. PubMed ID: 23877734
[TBL] [Abstract][Full Text] [Related]
19. Jak2 is a negative regulator of ubiquitin-dependent endocytosis of the growth hormone receptor.
Putters J; da Silva Almeida AC; van Kerkhof P; van Rossum AG; Gracanin A; Strous GJ
PLoS One; 2011 Feb; 6(2):e14676. PubMed ID: 21347402
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone receptor targeting to lipid rafts requires extracellular subdomain 2.
Yang N; Jiang J; Deng L; Waters MJ; Wang X; Frank SJ
Biochem Biophys Res Commun; 2010 Jan; 391(1):414-8. PubMed ID: 19914217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
